3Nguyen BN,Flejou JF,Terri B,et al.Focal nodular hyperplasia of the liver:a comprehensive pathologic study of 305 lesions and recognition of new histologic forms.Am J Surg Pathol,1999,23:1441-1454.
4Mathieu D,Kobeiter H,Maison P,et al.Oral contraceptive use and focal nodular hyperplasia of the liver.Gastroenterology,2000,118:560-564.
5Scalori A,Tavani A,Callus S,et al.Risk factors for focal nodular hyperplasia of the liver; an Italian case-control study.Am J Gastroenterol,2002,97:2371-2373.
6Bouyn CI,Leclere J,Raimondo G,et al.Hepatic focal nodular hyperplasia in children previously treated for a solid tumor:incidence,risk factors,and outcome.Cancer,2003,97:3107-3113.
7Hussain SM,Terkivatan T,Zondervan PE,et al.Focal nodular hyperplasia:findings at state of the art MR imaging,US,CT,and pathologic analysis.Radiographics,2004,24:3-17.
8Shiomi S,Kurooka H,Iwata Y,et al.Two cases of focal nodular hyperplasia of the liver:value of scintigraphy with Tc99m GSA and positron emission tomography with FDG.Ann Nucl Med,1999,13:427431.
9Kurtaran A,Becherer A,Pfefeel F,et al.18F-fluoredeoxy glucose(FDG) -PET features of focal nodular hyperplasia (FNH) of the liver.Liver,2000,20:487490.
10Grantzdorffer I,Lendeckel U,Cerl-McGrath S,et al.Angiotensin I-converting enzyme (CD 143) is down-regulated in focal nodular hyperplasia of the liver.Am J Surg Pathol,2004,28:84-88.
